v3.26.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (10,396,831) $ (3,876,859)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 124,938 695
Amortization of debt issuance costs and warrants 68,972
Changes in fair value of warrant liability (1,122,561)
Shares issued for services 289,200 346,588
Commitment shares issued for equity line of credit 568,235
Stock-based compensation expense 1,435,362 941,283
Changes in operating assets and liabilities:    
Prepaid expenses 63,082
Accounts payable and accrued expenses 3,882,449 (202,278)
Accrued interest on convertible notes 6,372
Accrued payroll and payroll taxes (37,082) (96,987)
Net cash used in operating activities (4,563,538) (3,441,884)
CASH FLOWS FROM INVESTING ACTIVITIES    
Shareholder loan repayment (23,636)
Patent license acquisition (150,000)
Net cash used in investing activities (173,636)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from warrant exercises (net of issuance costs) 3,376,260
Proceeds from convertible notes (net of issuance costs) 1,835,000
Sale of preferred stock and warrants 1,053,000
Net cash provided by financing activities 5,211,260 1,053,000
Net change in cash and cash equivalents 647,722 (2,562,520)
Cash and cash equivalents – beginning of period 269,830 5,533,527
Cash and cash equivalents – end of period 917,552 2,971,007
Cash paid for interest
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Warrants issued in connection with Convertible Bridge Notes 567,402
Shares issued for prepaid services $ 1,447,301